Hansa Biopharma AB (HNSBF)
2.90
0.00 (0.00%)
USD |
OTCM |
May 15, 16:00
Hansa Biopharma EPS Diluted (Quarterly) : -0.2111 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BONESUPPORT HOLDING AB | 0.0875 |
| BioInvent International AB | -0.1982 |
| BioArctic AB | -0.0106 |
| Swedish Orphan Biovitrum AB | 0.2064 |
| Egetis Therapeutics AB | 0.00 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.48M |
| Revenue (Quarterly) | 3.782M |
| Total Expenses (Quarterly) | 25.26M |
| Enterprise Value | 338.12M |
| Gross Profit Margin (Quarterly) | 60.14% |
| Profit Margin (Quarterly) | -567.9% |
| Earnings Yield | -28.58% |
| Normalized Earnings Yield | -26.48 |